RA Capital Management
Finance · Massachusetts, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
200 Berkeley St Ste 18, Boston, Massachu...Phone Number
(617) 778-2500Website
www.racap.comRevenue
$81.8 MillionIndustry
ZI Rank: 5
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
3
5
5
4
4
5
About RA Capital Management
RA Capital Management is a multi-stage investment manager focused on evidence-based investing in public and private healthcare and life science companies, including those developing drugs, medical devices, diagnostics, and research tools. The company also has a growing interest in climate and sustainability technologies. RA Capital aims to partner with innovators to bring ideas from the lab to the clinic, ultimately improving patient lives. Their internal think tank, TechAtlas, analyzes scientific and clinical data to support their investment strategies.Explore more
RA Capital Management Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is RA Capital Management your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
RA Capital Management, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on RA Capital Management recently announced quarterly report
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at RA Capital Management
Product Launch: Get notified when RA Capital Management launches new products
Check out if RA Capital Management is spiking on competitors!
Check if RA Capital Management has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once RA Capital Management has new funding data
Click to see if RA Capital Management had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at RA Capital Management
Find 3 more new buyers
Compare Similar Companies to RA Capital Management
Compare insights from companies similar to RA Capital Management, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
RA Capital Management is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
RA Capital Management is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about RA Capital Management.
RA Capital Management Tech Stack
A closer look at the technologies used by RA Capital Management
See more technologies
Most Recent Scoops
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Person-Based
Stake & Stock Ownership, Finance
RA Capital Management News & Media
Federal Jury Finds Avilar Therapeutics and RA Capital Willfully and Maliciously Misappropriated Trade Secret Developed at Yale, Awards Biohaven and Yale University $4 Million
NEW HAVEN, Conn., July 27, 2026 /PRNewswire/ -- Biohaven Ltd. and/or its wholly owned subsidiaries ("Biohaven") (NYSE: BHVN) and Yale University ("Yale") today announced that a federal jury in the U.S. District Court for the District of Delaware returned a verdict in their favor in the...NIMA and RA Capital Launch First-of-Its-Kind Workplace Pilot to Support Employees with Celiac Disease
NIMA and RA Capital launch first fully subsidized employer benefit providing gluten sensors to support employees with celiac disease and families.Memento Medicines Launches with $93 Million Series A Financing to advance Tie2 Agonist and VEGF Inhibitor Bispecific Antibody Therapy for Retinal Diseases
BOSTON, June 18, 2026 (GLOBE NEWSWIRE) -- Memento Medicines, Inc., a privately-held biotech company developing biologic therapies for retinal diseases, today announced the completion of a $93M Series A financing round co-led by Forbion, RA Capital Management and Avego BioScience Capital, with participation from Sanofi Ventures and Samsara BioCapital. In connection with the financing, Memento also announced that it has entered into an exclusive license agreement with MabTics Co., Ltd. and CuracleNexCure, Inc. Launches with $19 Million Series A Financing to enable CAR-T and other advanced treatment delivery in community outpatient settings
– NexCure founded by Raven, RA Capital's healthcare incubator, to address capacity constraints and access challenges for lifesaving therapies – – Financing led by RA Capital with participation from Cencora Ventures and Oncology Ventures – BOSTON, March 5, 2026 /PRNewswire/ -- NexCure, Inc....
Read more news
Top Finance Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding RA Capital Management
Sign Up For FreeTo access detailed company insights
RA Capital Management is a multi-stage investment manager focused on evidence-based investing in public and private healthcare and life science companies, including those developing drugs, medical devices, diagnostics, and research tools. The company also has a growing interest in climate and sustainability technologies. RA Capital aims to partner... Read More
